menu
    • menu

    Company profile for Stoke Therapeutics

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.

    Virtual Booth

    Contact Supplier

    Moehs Group, a reference company in the production of pharmaceutical active ingredients.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Stoke Therapeutics is a biotechnology company working to increase gene expression to treat a wide array of severe genetic diseases, including genetic conditions affecting the central nervous system, eye, ear, liver, and kidney.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Stoke TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    3 Preston Court, Suite 102 Bedford, MA 01730, USA
    Telephone
    Telephone
    781-430-8200
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.stoketherapeutics.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Stoke Therapeutics Inducement Grants per Nasdaq Rule 5635(c)(4)
    Stoke Therapeutics Inducement Grants per Nasdaq Rule 5635(c)(4)

    17 Dec 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-12-17/stoke-therapeutics-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4

    PHARMIWEB
    17 Dec 2025
    Share Share
    Stoke Therapeutics Grants Inducements Under Nasdaq Listing Rule
    Stoke Therapeutics Grants Inducements Under Nasdaq Listing Rule

    16 Dec 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251216645098/en/Stoke-Therapeutics-Announces-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635C4

    BUSINESSWIRE
    16 Dec 2025
    Share Share
    Stoke, Biogen Unveil Zorevunersen Data Syndrome for Dravet at AES
    Stoke, Biogen Unveil Zorevunersen Data Syndrome for Dravet at AES

    05 Dec 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-12-05/stoke-therapeutics-and-biogen-present-data-that-further-support-the-disease-modifying-potential-of-z

    PHARMIWEB
    05 Dec 2025
    Share Share
    Biogen, Stoke Announce Presentations at 2025 AES Annual Meeting
    Biogen, Stoke Announce Presentations at 2025 AES Annual Meeting

    01 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/01/3196905/0/en/Biogen-and-Stoke-Therapeutics-Announce-Presentations-at-the-2025-American-Epilepsy-Society-Annual-Meeting.html

    GLOBENEWSWIRE
    01 Dec 2025
    Share Share
    Stoke, Biogen Publish 2-Year Dravet Data
    Stoke, Biogen Publish 2-Year Dravet Data

    18 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251117517550/en/Stoke-Therapeutics-and-Biogen-Announce-Publication-of-Two-Year-Natural-History-Data-Demonstrating-the-Severity-of-Dravet-Syndrome-Including-Frequent-Seizures-and-Significant-Cognitive-and-Behavioral-Impairments

    BUSINESSWIRE
    18 Nov 2025
    Share Share
    Stoke Therapeutics Awards Inducement Grants Nasdaq LR
    Stoke Therapeutics Awards Inducement Grants Nasdaq LR

    18 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251118447114/en/Stoke-Therapeutics-Announces-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635C4

    BUSINESSWIRE
    18 Nov 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search